These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16184582)

  • 21. Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: could it be beneficial in early disease?
    Prutchi-Sagiv S; Golishevsky N; Oster HS; Katz O; Cohen A; Naparstek E; Neumann D; Mittelman M
    Br J Haematol; 2006 Dec; 135(5):660-72. PubMed ID: 17107348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thalidomide in combination with dexamethasone-induced rhabdomyolysis in a patient with refractory myeloma.
    Boga C; Ozdogu H; Yeral M; Kizilkilic E; Tamer L
    J Support Oncol; 2007 Jun; 5(6):256. PubMed ID: 17624049
    [No Abstract]   [Full Text] [Related]  

  • 23. Ultra low dose thalidomide in elderly patients with myeloma.
    Bowcock SJ; Minchom A; Yates LR; Ryali MM
    Br J Haematol; 2008 Apr; 141(1):120-2. PubMed ID: 18279458
    [No Abstract]   [Full Text] [Related]  

  • 24. Confirmation of the utility of the International Staging System and identification of a unique pattern of disease in Brazilian patients with multiple myeloma.
    Hungria VT; Maiolino A; Martinez G; Colleoni GW; Coelho EO; Rocha L; Nunes R; Bittencourt R; Oliveira LC; Faria RM; Pasquini R; Magalhães SM; Souza CA; Pinto Neto JV; Barreto L; Andrade E; Portella Mdo S; Bolejack V; Durie BG;
    Haematologica; 2008 May; 93(5):791-2. PubMed ID: 18450738
    [No Abstract]   [Full Text] [Related]  

  • 25. Pulmonary adenocarcinoma coexisting with multiple myeloma.
    Kocabay G; Erten N; Tiryaki B; Saka B; Tascioğlu C; Kalayoglu-besisik S
    Tuberk Toraks; 2008; 56(3):369-70. PubMed ID: 19145792
    [No Abstract]   [Full Text] [Related]  

  • 26. Case of multiple myeloma associated with extramedullary cutaneous plasmacytoma and pyoderma gangrenosum.
    Yoon YH; Cho WI; Seo SJ
    Int J Dermatol; 2006 May; 45(5):594-7. PubMed ID: 16700800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sjögren's syndrome associated with multiple myeloma.
    Tazi I; Rachid M; Benchekroun S
    Singapore Med J; 2008 Aug; 49(8):e215-6. PubMed ID: 18756337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Community experience with bortezomib in patients with multiple myeloma.
    Onitilo AA; Engel J; Olatosi B; Fagbemi S
    Am J Hematol; 2007 Jul; 82(7):637-9. PubMed ID: 17301970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell kinetics of multiple myeloma.
    Boccadoro M; Pileri A
    Hematol Pathol; 1987; 1(3):137-42. PubMed ID: 3334345
    [No Abstract]   [Full Text] [Related]  

  • 30. Epidemiology of multiple myeloma in Taiwan: increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years.
    Huang SY; Yao M; Tang JL; Lee WC; Tsay W; Cheng AL; Wang CH; Chen YC; Shen MC; Tien HF
    Cancer; 2007 Aug; 110(4):896-905. PubMed ID: 17594697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel agents in first-line therapy for myeloma.
    Jagannath S
    Oncology (Williston Park); 2005 Nov; 19(12):1551-4. PubMed ID: 16396150
    [No Abstract]   [Full Text] [Related]  

  • 32. Membranous glomerulonephritis--an under-reported histological finding in multiple myeloma.
    Thachil J; Sadik W; Shawki H; Abraham KA
    Nephrol Dial Transplant; 2009 May; 24(5):1695-6. PubMed ID: 19211651
    [No Abstract]   [Full Text] [Related]  

  • 33. Cutaneous involvement in multiple myeloma and bortezomib.
    Siniscalchi A; Fratoni S; Santeusanio G; Del Poeta G; de Fabritiis P; Caravita T
    Ann Hematol; 2009 Nov; 88(11):1137-9. PubMed ID: 19259673
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum concentrations of DKK-1 decrease in patients with multiple myeloma responding to anti-myeloma treatment.
    Heider U; Kaiser M; Mieth M; Lamottke B; Rademacher J; Jakob C; Braendle E; Stover D; Sezer O
    Eur J Haematol; 2009 Jan; 82(1):31-8. PubMed ID: 19067746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous infusion of pituitary adenylate cyclase-activating polypeptide (PACAP) in a patient with multiple myeloma and myeloma kidney: a case study.
    Li M; Maderdrut JL; Lertora JJ; Batuman V
    Peptides; 2007 Sep; 28(9):1891-5. PubMed ID: 17582655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple myeloma and systemic lupus erythematosus in a young woman.
    Okoli K; Irani F; Horvath W
    J Clin Rheumatol; 2009 Sep; 15(6):292-4. PubMed ID: 19734735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anion gap among patients of multiple myeloma and normal individuals.
    Mansoor S; Siddiqui I; Adil S; Nabi Kakepoto G; Fatmi Z; Ghani F
    Clin Biochem; 2007 Feb; 40(3-4):226-9. PubMed ID: 17156769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bortezomib in combination with conventional chemotherapeutic agents for multiple myeloma compared with bortezomib alone.
    Min CK; Lee MJ; Eom KS; Lee S; Lee JW; Min WS; Kim CC; Kim M; Lim J; Kim Y; Han K
    Jpn J Clin Oncol; 2007 Dec; 37(12):961-8. PubMed ID: 18156171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time to first disease progression, but not beta2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy.
    Palumbo A; Bringhen S; Falco P; Cavallo F; Ambrosini MT; Avonto I; Gay F; Caravita T; Bruno B; Boccadoro M
    Cancer; 2007 Aug; 110(4):824-9. PubMed ID: 17594696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [50-year-old man with fatigue and monoclonal gammopaty].
    Raeder H; Kildahl-Andersen O; Stalsberg H
    Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2677-9. PubMed ID: 17972388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.